S100A9 and urinary bladder cancer: Moreover, S100A9 overexpression can lead to resistance to cisplatin-induced apoptosis in bladder cancer, whereas S100A9 inhibition can enhance tumor cell sensitization to cisplatin-induced apoptosis (Kim et al., 2014).